Molecular characterization of patients with a clinical diagnosis of Lynch syndrome currently relies on the identification of point mutations and large rearrangements [85, 86] by DHPLC and MLPA, respectively, in the major MMR genes, MLH1 and MSH2. This evidence concerns the gene MLH1 and Lynch syndrome.